Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Roche reaffirms commitment to Hematology Testing

Authored by James Sheppard

Global pharmaceutical company Roche announced that its diagnostic division, Roche Diagnostics, had completed the acquisition of the USA based developer Constitution Medical Inc (CMI). CMI are based in the Boston biotech cluster and develop innovative hematology testing systems designed to provide faster and more accurate diagnosis of blood-related diseases and improving patient care.

The deal which will give Roche Diagnostics access to CMI’s Bloodhound technology. Bloodhound is a fully automated system in development with the capability to increase efficiency and save lab space. CMI will serve as a centre of excellence in the field of hematology within the Roche Diagnostic business.

Roland Diggelmann, COO of Roche Diagnostics, stated ‘with this acquisition, we will further strengthen our commitment to hematology and drive towards integrated laboratory solutions with innovative products which deliver medical value to our customers and patients. Patients will benefit from faster and more accurate diagnosis of blood diseases such and anaemia and leukaemia.’

The deal which is estimated to be over $250m consisted of a $220m upfront payment as well as further contingency payments depending on the performance of certain products. CMI was created by the private equity firm Warburg Pincus and the CMI management team. The deal caps a good first half of 2013 for Warburg Pincus following on from there $8.7bn sale of Bausch & Lomb to the Canadian pharma company Valeant.

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap